甘露糖结合凝集素与2型糖尿病心血管事件及死亡风险:一项丹麦队列研究
在7588例2型糖尿病患者的丹麦队列中,检测7305例血清MBL并对3043例进行MBL表达基因分型。血清MBL与心血管事件呈U形关联,低和高MBL类别的校正HR分别为1.82和1.48;MBL表达基因型与心血管事件也呈U形关联,但与全因死亡无关。
要点
- 血清MBL与心血管事件呈U形关联,低和高MBL类别风险均高于中间类别。
- MBL表达基因型与心血管事件呈U形关联,高表达基因型校正HR为1.44。
- MBL表达基因型与全因死亡无关联。
核心结论
- 血清MBL和MBL表达基因型均与2型糖尿病个体心血管事件风险呈U形关联。
- 作者认为血清MBL是该人群心血管疾病的风险因素。
研究设计与样本
- 丹麦队列研究,纳入7588例2型糖尿病患者,其中7305例检测血清MBL,3043例进行MBL表达基因分型。
- 血清MBL和MBL表达基因型均分为低、中、高三个类别。
- 结局为心血管事件(心肌梗死、卒中、冠状动脉血运重建、不稳定型心绞痛或心血管死亡)和全因死亡。
- 采用样条分析和Cox回归分析评估关联。
主要发现
- 血清MBL与心血管事件呈U形关联:与中间血清MBL类别相比,低MBL类别校正HR为1.82(95%CI 1.34-2.46),高MBL类别校正HR为1.48(95%CI 1.14-1.92)。
- 血清MBL与全因死亡也呈U形关联,但风险估计值较低。
- 与中间MBL表达基因型相比,低表达基因型心血管事件校正HR为1.40(95%CI 0.87-2.25),高表达基因型校正HR为1.44(95%CI 1.01-2.06)。
- MBL表达基因型与全因死亡无关联。
关键数值与推荐
- 血清MBL低类别 vs 中间类别:心血管事件校正HR 1.82(95%CI 1.34-2.46)。
- 血清MBL高类别 vs 中间类别:心血管事件校正HR 1.48(95%CI 1.14-1.92)。
- MBL表达基因型低表达 vs 中间:心血管事件校正HR 1.40(95%CI 0.87-2.25)。
- MBL表达基因型高表达 vs 中间:心血管事件校正HR 1.44(95%CI 1.01-2.06)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Mannose-binding lectin (MBL) is linked to risk of cardiovascular disease (CVD) in diabetes, but the nature of the association is unclear. We investigated the association between MBL and the risk of cardiovascular events (CVE) and all-cause mortality in type 2 diabetes. RESEARCH DESIGN AND METHODS: In a cohort study of 7,588 patients with type 2 diabetes, we measured serum MBL in 7,305 patients and performed MBL expression genotyping in 3,043 patients. We grouped serum MBL and MBL expression genotypes into three categories: low, intermediate, and high. Outcomes were CVE (myocardial infarction, stroke, coronary revascularization, unstable angina, or cardiovascular death) and all-cause mortality. The association with outcomes was examined by spline and Cox regression analyses. RESULTS: Serum MBL and CVE showed a U-shaped association. Compared with the intermediate serum MBL category, the adjusted hazard ratio (HR) for CVE was 1.82 (95% CI 1.34-2.46) for the low-MBL category and 1.48 (95% CI 1.14-1.92) for the high-MBL category. We found a similar U-shaped association for all-cause mortality, but with lower risk estimates. Compared with the intermediate MBL expression genotype, the adjusted HR for CVE was 1.40 (95% CI 0.87-2.25) for the low-expression genotype and 1.44 (95% CI 1.01-2.06) for the high-expression genotype. MBL expression genotype was not associated with all-cause mortality. CONCLUSIONS: Both serum MBL and MBL expression genotype showed a U-shaped association with CVE risk in individuals with type 2 diabetes. Our findings suggest that serum MBL is a risk factor for CVD in this population.
引用
- Gedebjerg A, Bjerre M, Kjaergaard AD, et al. Mannose-Binding Lectin and Risk of Cardiovascular Events and Mortality in Type 2 Diabetes: A Danish Cohort Study. Diabetes Care. 2020. PMID: 32616614. doi:10.2337/dc20-0345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。